NEI Podcast cover image

E161 - Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Real-World Setting Among Patients with Treatment Refractory Depression

NEI Podcast

00:00

Intravenous Ketamine vs. Intranasal Eskeamine for Treatment Resistant Depression

Intravenous eskeamine, one of the first randomized controlled trial I was published in 2006. The intranasal eskeamine got the FDA approval in 2019. But at this moment, there is no head-to-head randomized controlled trial comparing these two interventions. So that was the kind of main reason when we designed this study to explore these two different interventions.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app